Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.
Also called NCT06393348
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 155 participants
- Registry
-
NCT06393348
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06393348. Randomized; double masking; primary purpose other. Start 2024-05-17 (actual); primary completion 2024-11-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HRS-7535
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06393348- Content hash
9ccb3184de4d694574df2a790ea90d16d425c5b54fc339cab2d6232a288b0038